11.30
-0.19 (-1.65%)
前收盘价格 | 11.49 |
收盘价格 | 11.48 |
成交量 | 372,901 |
平均成交量 (3个月) | 333,057 |
市值 | 442,743,040 |
预期市盈率 (P/E Forward) | 20.04 |
价格/销量 (P/S) | 0.670 |
股市价格/股市净资产 (P/B) | 1.10 |
52周波幅 | |
利润日期 | 4 Aug 2025 - 8 Aug 2025 |
营业毛利率 | -15.76% |
营业利益率 (TTM) | -3.59% |
稀释每股收益 (EPS TTM) | -3.30 |
季度收入增长率 (YOY) | 7.60% |
总债务/股东权益 (D/E MRQ) | 38.50% |
流动比率 (MRQ) | 2.57 |
营业现金流 (OCF TTM) | 25.79 M |
杠杆自由现金流 (LFCF TTM) | 55.42 M |
资产报酬率 (ROA TTM) | -4.50% |
股东权益报酬率 (ROE TTM) | -22.87% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (US) | 看跌 | 混合的 |
Medical Devices (全球的) | 看跌 | 混合的 | |
股票 | Orthofix Medical Inc. | 混合的 | 看涨 |
AIStockmoo 评分
分析师共识 | -2.0 |
内部交易活动 | NA |
价格波动 | 3.0 |
技术平均移动指标 | 2.5 |
技术振荡指标 | -2.5 |
平均 | 0.25 |
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Small Value |
内部持股比例 | 5.32% |
机构持股比例 | 87.64% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Engine Capital Management, Lp | 31 Mar 2025 | 3,741,390 |
Rubric Capital Management Lp | 31 Mar 2025 | 3,694,946 |
Paradigm Capital Management Inc/Ny | 31 Mar 2025 | 2,481,700 |
Juniper Investment Company, Llc | 31 Mar 2025 | 2,137,374 |
Boone Capital Management Llc | 31 Mar 2025 | 948,202 |
Emerald Advisers, Llc | 31 Mar 2025 | 811,138 |
Ayal Capital Advisors Ltd | 31 Mar 2025 | 539,770 |
Emerald Mutual Fund Advisers Trust | 31 Mar 2025 | 514,524 |
该时间范围内无数据。
该时间范围内无数据。
日期 | 类型 | 细节 |
---|---|---|
06 May 2025 | 公告 | Orthofix Reports First Quarter 2025 Financial Results |
15 Apr 2025 | 公告 | Orthofix to Report First Quarter 2025 Financial Results |
19 Mar 2025 | 公告 | Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System |
12 Mar 2025 | 公告 | Orthofix Announces Appointment of Vickie Capps to Board of Directors |
03 Mar 2025 | 公告 | Orthofix to Participate in the 37th Annual Roth Conference |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合